EF
JAZZ icon

Empowered Funds’s Jazz Pharmaceuticals JAZZ Stock Holding History

Empowered Funds’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.7M Buy
106,854
+92,618
+651% +$20.3M 0.14% 147
2026
Q1 		$2.69M Buy
14,236
+362
+3% +$63.3K 0.02% 936
2025
Q4 		$2.36M Sell
13,874
-1,095
-7% -$168K 0.04% 438
2025
Q3 		$1.97M Buy
14,969
+1,530
+11% +$184K 0.02% 926
2025
Q2 		$1.43M Buy
+13,439
New +$1.46M 0.02% 956
2024
Q1 		– Sell
-18,562
Closed -$2.28M – 1409
2023
Q4 		$2.28M Buy
18,562
+131
+0.7% +$16.3K 0.06% 479
2023
Q3 		$2.39M Buy
+18,431
New +$2.46M 0.07% 398

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Empowered Funds's JAZZ Position: Q2 2026 in Review

Empowered Funds increased its Jazz Pharmaceuticals (JAZZ) stake by 651% in Q2 2026, buying an estimated $20.3M and bringing the position to 106,854 shares worth $25.7M. The position accounts for 0.14% of the portfolio, ranked #147.

Empowered Funds first reported a position in JAZZ in Q3 2023 and has held it in 7 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Empowered Funds held 106,854 shares of Jazz Pharmaceuticals worth $25.7M as of Q2 2026.
  • Empowered Funds bought 92,618 Jazz Pharmaceuticals shares in Q2 2026, an estimated $20.3M.
  • Jazz Pharmaceuticals made up 0.14% of Empowered Funds's portfolio in Q2 2026, its #147 holding.
  • Empowered Funds first reported a position in Jazz Pharmaceuticals in Q3 2023 and has held it in 7 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.